HNF4A (P41235) variants and mutations
HNF4A (also known as P41235) is a human protein-coding gene encoding a hepatocyte nuclear factor 4-alpha protein. It coordinates transcription of genes involved in hepatic metabolism and pancreatic beta-cell function. Heterozygous pathogenic variants can cause maturity-onset diabetes of the young, often with fetal overgrowth and transient neonatal hyperinsulinemic hypoglycemia in affected families. This analysis covers 794 HNF4A variants and mutations. Of these, 70% have computational variant effect predictions. Disease context includes MODY, type 2 diabetes mellitus, and renal cysts and diabetes syndrome. Example HNF4A variants include R2*, R2Q, and R2R.
Variant analysis overview
- Gene: HNF4A
- Protein: P41235
- UniProt accession: P41235
- Organism: Homo sapiens
- Variants analyzed: 794
- Variant scope: all variants
- Completed: 2026-08-20
Variant and mutation evidence
- Variant composition: 627 unspecified-consequence records; 36 synonymous variants; 113 missense variants; 5 stop-gained variants; 2 splice-region variants; 7 frameshift variants; 1 in-frame deletions; 1 in-frame insertions; 2 substitution
- Prediction scores: 558 variants have prediction scores (70% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: MODY, type 2 diabetes mellitus, renal cysts and diabetes syndrome, maturity-onset diabetes of the young, monogenic diabetes, diabetes mellitus, cholelithiasis, gallstones, Intrahepatic cholestasis of pregnancy, gastrointestinal disease, Cholecystitis, hyperinsulinism due to HNF4A deficiency.
Protein structure and variant hotspots
- Protein features: 1 domains; 10 post-translational modification sites.
- Structural context: 304 variants have structural context.
- PTM context: 11 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Notable HNF4A variants
Examples include R2*, R2Q, R2R, R2P, L3F, L3P, L3N, L3L. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- R2* (p.Arg2Ter), rs755329974, ClinGen CA9870061, NCI-TCGA Cosmic COSV1002, cosmic curated COSV10029, CADD 37.00, Uncertain significance
- R2Q (p.Arg2Gln), rs781467980, NCI-TCGA Cosmic COSV1002, cosmic curated COSV10029, ExAC rs781467980, REVEL 0.53, MetaLR 0.74, Variant assessed as somatic; moderate impact.
- R2R (p.Arg2Arg), rs755329974, gnomAD 20-44401376-C-A, CADD 13.70
- R2P (p.Arg2Pro), gnomAD 20-44401377-G-C, REVEL 0.59, CADD 30.00
- L3F (p.Leu3Phe), gnomAD rs1423549831, REVEL 0.52, MetaLR 0.81
- L3P (p.Leu3Pro), TOPMed rs1198255545, gnomAD rs1198255545, REVEL 0.71, MetaLR 0.83
- L3N (p.Leu3Asn), rs1253819799, gnomAD 20-44401377-G-GAA, CADD 28.60
- L3L (p.Leu3Leu), rs748558393, gnomAD 20-44401381-C-T, CADD 11.60
- S4Q (p.Ser4Gln), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- S4R (p.Ser4Arg), rs779464983, gnomAD 20-44355811-A-C, CADD 24.30
- S4G (p.Ser4Gly), rs779464983, gnomAD 20-44355811-A-G, CADD 22.90
- S4S (p.Ser4Ser), gnomAD 20-44355813-C-T, CADD 14.10
- S4A (p.Ser4Ala), gnomAD 20-44390643-T-G, CADD 19.80
- S4L (p.Ser4Leu), rs780566668, gnomAD 20-44390644-C-T, CADD 21.10
- S4* (p.Ser4Ter), gnomAD 20-44390644-C-A, CADD 21.40
- S4W (p.Ser4Trp), rs780566668, gnomAD 20-44390644-C-G, CADD 21.50
- K5E (p.Lys5Glu), TOPMed rs1386633021, gnomAD rs1386633021, REVEL 0.39, MetaLR 0.53
- K5N (p.Lys5Asn), gnomAD 20-44401387-A-C, REVEL 0.38, CADD 23.20
- T6P (p.Thr6Pro), TOPMed rs2063406279
- T6A (p.Thr6Ala), gnomAD 20-44401388-A-G, REVEL 0.21, CADD 22.10
- T6N (p.Thr6Asn), gnomAD 20-44401389-C-A, REVEL 0.39, CADD 21.60
- T6T (p.Thr6Thr), gnomAD 20-44401390-C-G, CADD 9.95
- L7V (p.Leu7Val), rs775770184, gnomAD 20-44355826-C-G, CADD 17.70
- L7F (p.Leu7Phe), rs775770184, gnomAD 20-44355826-C-T, CADD 22.40
- L7L (p.Leu7Leu), rs761046168, gnomAD 20-44355828-C-T, CADD 11.30
- V8G (p.Val8Gly), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- V8I (p.Val8Ile), rs537703038, NCI-TCGA Cosmic COSV1002, cosmic curated COSV10029, 1000Genomes rs537703038, REVEL 0.26, MetaLR 0.47, Variant assessed as somatic; moderate impact.
- V8V (p.Val8Val), gnomAD 20-44355810-C-A, CADD 14.50
- V8M (p.Val8Met), rs746433493, gnomAD 20-44355814-G-A, CADD 24.10
- V8A (p.Val8Ala), rs754071908, gnomAD 20-44355839-T-C, CADD 22.20
- D9N (p.Asp9Asn), rs1463436840, NCI-TCGA Cosmic COSV5738, cosmic curated COSV57388, TOPMed rs1463436840, REVEL 0.63, MetaLR 0.83, Variant assessed as somatic; moderate impact.
- D9Y (p.Asp9Tyr), TOPMed rs1463436840, gnomAD rs1463436840
- D9G (p.Asp9Gly), rs1198174462, gnomAD 20-44390647-A-G, CADD 16.80
- M10L (p.Met10Leu), ExAC rs775567227, TOPMed rs775567227, gnomAD rs775567227
- M10T (p.Met10Thr), Ensembl rs2063406610, REVEL 0.82, MetaLR 0.87
- M10V (p.Met10Val), cosmic curated COSV10733, ExAC rs775567227, TOPMed rs775567227, gnomAD rs775567227, REVEL 0.81, MetaLR 0.84
- M10R (p.Met10Arg), gnomAD 20-44401401-T-G, REVEL 0.81, CADD 29.20
- D11N (p.Asp11Asn), rs200655531, NCI-TCGA Cosmic COSV1002, cosmic curated COSV10029, 1000Genomes rs200655531, CADD 15.20, SIFT 0.58, Variant assessed as somatic; moderate impact.
- D11E (p.Asp11Glu), gnomAD 20-44390672-C-G, CADD 12.20
- D11V (p.Asp11Val), gnomAD 20-44401404-A-T, REVEL 0.66, CADD 28.90
- M12L (p.Met12Leu), gnomAD rs1394031320, REVEL 0.38, MetaLR 0.75
- M12T (p.Met12Thr), gnomAD rs1316900220, REVEL 0.62, MetaLR 0.80
- M12V (p.Met12Val), gnomAD 20-44401406-A-G, REVEL 0.46, CADD 21.60
- A13T (p.Ala13Thr), rs2062850800, gnomAD 20-44355820-G-A, CADD 22.50
- A13V (p.Ala13Val), rs1051122101, gnomAD 20-44355821-C-T, CADD 19.30
- A13E (p.Ala13Glu), rs1051122101, gnomAD 20-44355821-C-A, CADD 18.90
- A13P (p.Ala13Pro), rs1329019664, gnomAD 20-44355832-G-C, CADD 23.90
- A13A (p.Ala13Ala), rs772889022, gnomAD 20-44355834-T-C, CADD 14.70
- D14N (p.Asp14Asn), ExAC rs761696474, gnomAD rs761696474, REVEL 0.26, MetaLR 0.65
- D14Y (p.Asp14Tyr), gnomAD 20-44390679-G-T, CADD 24.50
- D14H (p.Asp14His), gnomAD 20-44401412-G-C, REVEL 0.64, CADD 31.00
- Y15N (p.Tyr15Asn), gnomAD 20-44355850-T-A, CADD 22.80
- Y15Y (p.Tyr15Tyr), gnomAD 20-44355852-C-T, CADD 14.60
- S16G (p.Ser16Gly), ExAC rs765342557, TOPMed rs765342557, gnomAD rs765342557, REVEL 0.28, MetaLR 0.62
- S16R (p.Ser16Arg), rs1372560432, gnomAD 20-44355844-A-C, CADD 20.20
- S16Y (p.Ser16Tyr), rs1410986201, gnomAD 20-44355848-C-A, CADD 24.70
- S16S (p.Ser16Ser), rs1045158502, gnomAD 20-44355849-T-G, CADD 12.20
- A17T (p.Ala17Thr), Ensembl rs2146340505, REVEL 0.27, MetaLR 0.64
- A17V (p.Ala17Val), gnomAD 20-44401422-C-T, REVEL 0.19, CADD 22.20
- A17A (p.Ala17Ala), gnomAD 20-44401423-T-G, CADD 3.67
- A18T (p.Ala18Thr), ExAC rs750703108, TOPMed rs750703108, gnomAD rs750703108, REVEL 0.30, MetaLR 0.68
- A18V (p.Ala18Val), gnomAD 20-44401425-C-T, REVEL 0.22, CADD 22.70
- L19P (p.Leu19Pro), rs2063407237, ClinGen CA409103125, NCI-TCGA Cosmic COSV1002, cosmic curated COSV10029, REVEL 0.74, MetaLR 0.88, Uncertain significance/Uncertain risk allele, Maturity-onset diabetes of the young; Maturity-onset diabetes of the young type
- D20T (p.Asp20Thr), rs2063407285, gnomAD 20-44401428-TG-T, CADD 27.10
- P21A (p.Pro21Ala), gnomAD rs2063407337, REVEL 0.72, MetaLR 0.83
- P21R (p.Pro21Arg), gnomAD 20-44355824-C-G, CADD 23.90
- P21L (p.Pro21Leu), gnomAD 20-44355824-C-T, CADD 25.60
- P21P (p.Pro21Pro), rs1186838248, gnomAD 20-44355825-C-T, CADD 13.80
- P21S (p.Pro21Ser), gnomAD 20-44355835-C-T, CADD 21.10
- P21T (p.Pro21Thr), rs1411667013, gnomAD 20-44390664-C-A, CADD 15.60
- P21Q (p.Pro21Gln), gnomAD 20-44390677-C-A, CADD 20.60
- A22D (p.Ala22Asp), ExAC rs758457314, TOPMed rs758457314, gnomAD rs758457314, REVEL 0.61, MetaLR 0.80
- A22A (p.Ala22Ala), rs766511087, gnomAD 20-44401438-C-T, CADD 14.40
- Y23C (p.Tyr23Cys), gnomAD 20-44401440-A-G, REVEL 0.66, CADD 31.00
- Y23Y (p.Tyr23Tyr), rs377103999, gnomAD 20-44401441-C-T, CADD 10.80
- T24S (p.Thr24Ser), ESP rs369693799, ExAC rs369693799, TOPMed rs369693799, gnomAD rs369693799, REVEL 0.51, MetaLR 0.68
- T25A (p.Thr25Ala), gnomAD 20-44401445-A-G, REVEL 0.30, CADD 22.90
- T25I (p.Thr25Ile), gnomAD 20-44401446-C-T, REVEL 0.66, CADD 25.10
- L26V (p.Leu26Val), gnomAD rs1245414025, REVEL 0.40, MetaLR 0.86
- L26L (p.Leu26Leu), gnomAD 20-44401450-G-A, CADD 11.60
- E27A (p.Glu27Ala), cosmic curated COSV57379, ExAC rs781738246, gnomAD rs781738246, REVEL 0.62, MetaLR 0.83
- E27* (p.Glu27Ter), gnomAD 20-44355841-G-T, CADD 40.00
- E27G (p.Glu27Gly), gnomAD 20-44355842-A-G, CADD 23.50
- F28L (p.Phe28Leu), gnomAD 20-44390661-T-C, CADD 8.85
- F28F (p.Phe28Phe), rs549449127, gnomAD 20-44390663-C-T, CADD 14.20
- F28Y (p.Phe28Tyr), gnomAD 20-44401455-T-A, REVEL 0.59, CADD 27.00
- E29A (p.Glu29Ala), gnomAD 20-44401458-A-C, REVEL 0.69, CADD 28.00
- N30H (p.Asn30His), gnomAD rs1187579643, REVEL 0.39, MetaLR 0.75
- N30N (p.Asn30Asn), rs772641374, gnomAD 20-44355819-C-T, CADD 9.88
- N30K (p.Asn30Lys), gnomAD 20-44355819-C-A, CADD 23.40
- V31A (p.Val31Ala), ExAC rs752973948, gnomAD rs752973948, REVEL 0.25, MetaLR 0.56
- V31M (p.Val31Met), gnomAD 20-44401463-G-A, REVEL 0.30, CADD 21.70
- Q32* (p.Gln32Ter), rs1053493163, gnomAD 20-44390655-C-T, CADD 20.80
- Q32E (p.Gln32Glu), gnomAD 20-44390667-C-G, CADD 10.30
- Q32K (p.Gln32Lys), gnomAD 20-44390667-C-A, CADD 10.10
- Q32Q (p.Gln32Gln), gnomAD 20-44390669-G-A, CADD 15.50
- Q32H (p.Gln32His), gnomAD 20-44390669-G-T, CADD 15.20
- V33M (p.Val33Met), rs1170574009, ClinGen CA409103270, ClinVar RCV003228604, gnomAD rs1170574009, AlphaMissense 0.09, MetaLR 0.74, Uncertain significance, Maturity-onset diabetes of the young type 1; Type 2 diabetes mellitus
- V33V (p.Val33Val), gnomAD 20-44401471-G-C, CADD 10.40
- L34M (p.Leu34Met), NCI-TCGA Cosmic COSV5738, cosmic curated COSV57387, Variant assessed as somatic; moderate impact.
- T35K (p.Thr35Lys), NCI-TCGA Cosmic COSV5738, cosmic curated COSV57384, Variant assessed as somatic; moderate impact.
- T35M (p.Thr35Met), cosmic curated COSV10441, ExAC rs756553207, TOPMed rs756553207, gnomAD rs756553207, REVEL 0.31, MetaLR 0.72
- T35T (p.Thr35Thr), rs778418332, gnomAD 20-44401477-G-A, CADD 6.18
- M36I (p.Met36Ile), ExAC rs745604501, TOPMed rs745604501, gnomAD rs745604501, REVEL 0.19, MetaLR 0.61
- M36T (p.Met36Thr), TOPMed rs899205490
- G37D (p.Gly37Asp), NCI-TCGA Cosmic COSV1002, cosmic curated COSV10029, Variant assessed as somatic; moderate impact.
- G37S (p.Gly37Ser), Ensembl rs2063408168
- G37R (p.Gly37Arg), rs769394388, gnomAD 20-44355829-G-A, CADD 22.40
- G37G (p.Gly37Gly), rs889744956, gnomAD 20-44355831-G-T, CADD 11.60
- G37V (p.Gly37Val), gnomAD 20-44390653-G-T, CADD 18.00
- G37A (p.Gly37Ala), gnomAD 20-44390656-AG-A, CADD 18.20
- N38D (p.Asn38Asp), ExAC rs746544497, TOPMed rs746544497, gnomAD rs746544497, REVEL 0.20, MetaLR 0.60
- N38K (p.Asn38Lys), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- N38T (p.Asn38Thr), ExAC rs768670371, TOPMed rs768670371, gnomAD rs768670371, REVEL 0.19, MetaLR 0.37, Benign, Monogenic diabetes
- D39G (p.Asp39Gly), gnomAD rs1462526900, REVEL 0.48, MetaLR 0.58
- D39D (p.Asp39Asp), rs1386050715, gnomAD 20-44401794-C-T, CADD 3.95
- T40M (p.Thr40Met), rs199796094, ClinGen CA9870157, ClinVar RCV000711953, ClinVar RCV000764240, REVEL 0.29, MetaLR 0.67, Uncertain significance, Type 2 diabetes mellitus; Maturity-onset diabetes of the young type 1; Fanconi r
- T40I (p.Thr40Ile), rs1449040232, gnomAD 20-44401763-C-T, CADD 2.51
- S41C (p.Ser41Cys), rs2515643997, ClinGen CA409103665, ClinVar RCV003834006, REVEL 0.34, MetaLR 0.77, Uncertain significance, not provided
- S43* (p.Ser43Ter), rs2515644041, NCI-TCGA Cosmic COSV1002, cosmic curated COSV10029, ClinVar RCV004574968, Pathogenic
- E44Q (p.Glu44Gln), NCI-TCGA Cosmic COSV1002, cosmic curated COSV10029, Variant assessed as somatic; moderate impact.
- G45C (p.Gly45Cys), Ensembl rs2063495593
- G45D (p.Gly45Asp), rs773661614, ClinGen CA9870159, ClinVar RCV000992159, ClinVar RCV003148903, REVEL 0.24, MetaLR 0.58, Uncertain significance, Maturity-onset diabetes of the young; not provided
- G45S (p.Gly45Ser), Ensembl rs2063495593, REVEL 0.25, MetaLR 0.37
- G45A (p.Gly45Ala), rs1270936454, gnomAD 20-44401778-G-C, CADD 4.35
- G45G (p.Gly45Gly), rs1355578151, gnomAD 20-44401779-C-T, CADD 0.02
- N47K (p.Asn47Lys), Ensembl rs2146367560
- L48F (p.Leu48Phe), cosmic curated COSV10733, TOPMed rs753285226, gnomAD rs753285226, REVEL 0.24, MetaLR 0.67, Uncertain significance
- L48I (p.Leu48Ile), rs753285226, ClinGen CA315403984, ClinVar RCV002265518, ClinVar RCV002481076, REVEL 0.23, MetaLR 0.63, Uncertain significance, not provided; Maturity-onset diabetes of the young type 1; Type 2 diabetes melli
- L48L (p.Leu48Leu), rs1209687173, gnomAD 20-44401773-G-C, CADD 8.09
- A50P (p.Ala50Pro), TOPMed rs1223493898, gnomAD rs1223493898, REVEL 0.23, MetaLR 0.75
- A50T (p.Ala50Thr), rs1223493898, NCI-TCGA Cosmic COSV1002, cosmic curated COSV10029, TOPMed rs1223493898, REVEL 0.19, MetaLR 0.52, Variant assessed as somatic; moderate impact.
- A50V (p.Ala50Val), rs140143857, ClinGen CA9870161, ClinVar RCV001288636, ClinVar RCV003148967, REVEL 0.19, MetaLR 0.65, Uncertain significance, Monogenic diabetes
- P51H (p.Pro51His), rs763529905, ClinGen CA9870163, ClinVar RCV002680738, ClinVar RCV004999793, REVEL 0.32, MetaLR 0.72, Conflicting interpretations, not specified; not provided
- P51R (p.Pro51Arg), NCI-TCGA Cosmic COSV5737, cosmic curated COSV57378, Variant assessed as somatic; moderate impact.
- P51S (p.Pro51Ser), rs1489609624, gnomAD 20-44402563-C-T, CADD 2.96
- P51Q (p.Pro51Gln), gnomAD 20-44402564-C-A, CADD 0.98
- P51L (p.Pro51Leu), rs768327289, gnomAD 20-44402564-C-T, CADD 1.30
- P51T (p.Pro51Thr), rs2146345596, gnomAD 20-44402590-C-A, CADD 1.45
- N52S (p.Asn52Ser), Ensembl rs2063496010
- S53I (p.Ser53Ile), NCI-TCGA Cosmic COSV1002, REVEL 0.27, MetaLR 0.67, Variant assessed as somatic; moderate impact.
- S53N (p.Ser53Asn), NCI-TCGA Cosmic COSV1002, cosmic curated COSV10029, Variant assessed as somatic; moderate impact.
- L54M (p.Leu54Met), NCI-TCGA Cosmic COSV5738, cosmic curated COSV57386, Variant assessed as somatic; moderate impact.
- L54C (p.Leu54Cys), gnomAD 20-44402554-AT-A, CADD 8.54
- L54S (p.Leu54Ser), gnomAD 20-44402558-T-C, CADD 7.50
- L54F (p.Leu54Phe), rs758079111, gnomAD 20-44402559-G-C, CADD 6.73
- L54W (p.Leu54Trp), rs746482984, gnomAD 20-44402561-T-G, CADD 0.79
- L54P (p.Leu54Pro), gnomAD 20-44402567-T-C, CADD 0.54
- G55C (p.Gly55Cys), NCI-TCGA Cosmic COSV1002, cosmic curated COSV10029, Variant assessed as somatic; moderate impact.
- G55D (p.Gly55Asp), TOPMed rs2063496148, REVEL 0.73, MetaLR 0.80
- V56D (p.Val56Asp), rs2063496235, ClinGen CA409103758, ClinVar RCV001195383, ClinVar RCV002365894, AlphaMissense 0.40, MetaLR 0.70, Uncertain significance/Uncertain risk allele, Maturity-onset diabetes of the young; not specified
- V56M (p.Val56Met), rs2071197, gnomAD 20-44401795-G-A, CADD 0.01
- V56A (p.Val56Ala), rs995010217, gnomAD 20-44401796-T-C, CADD 1.80
- S57I (p.Ser57Ile), ExAC rs201545824, TOPMed rs201545824, gnomAD rs201545824, REVEL 0.46, MetaLR 0.79
- S57N (p.Ser57Asn), ExAC rs201545824, TOPMed rs201545824, gnomAD rs201545824, REVEL 0.23, MetaLR 0.67
- S57R (p.Ser57Arg), rs199678287, ExAC rs199678287, TOPMed rs199678287, gnomAD rs199678287, REVEL 0.30, MetaLR 0.74, Variant assessed as somatic; moderate impact.
- A58P (p.Ala58Pro), ESP rs376906221, ExAC rs376906221, TOPMed rs376906221, gnomAD rs376906221, REVEL 0.29, MetaLR 0.69, Uncertain significance
- A58S (p.Ala58Ser), ESP rs376906221, ExAC rs376906221, TOPMed rs376906221, gnomAD rs376906221, REVEL 0.23, MetaLR 0.53, Uncertain significance
- A58T (p.Ala58Thr), rs376906221, ClinGen CA9870168, cosmic curated COSV57380, ClinVar RCV001941149, REVEL 0.21, MetaLR 0.68, Uncertain significance, Maturity-onset diabetes of the young type 1; Fanconi renotubular syndrome 4 with
- A58V (p.Ala58Val), NCI-TCGA Cosmic COSV5738, cosmic curated COSV57383, REVEL 0.25, MetaLR 0.67, Variant assessed as somatic; moderate impact.
- L59P (p.Leu59Pro), NCI-TCGA TCGA novel, Ensembl rs2063496560, REVEL 0.76, MetaLR 0.84, Variant assessed as somatic; high impact.
- p.Leu58 Leu61del, gnomAD 20-44402570-GTCTC, CADD 5.73
- L59R (p.Leu59Arg), rs1402632426, gnomAD 20-44402573-T-G, CADD 2.44
- L59W (p.Leu59Trp), rs752726625, gnomAD 20-44402582-T-G, CADD 2.59
- A61P (p.Ala61Pro), NCI-TCGA Cosmic COSV5738, cosmic curated COSV57383, Variant assessed as somatic; moderate impact.
- I62M (p.Ile62Met), NCI-TCGA Cosmic COSV1002, cosmic curated COSV10029, Variant assessed as somatic; moderate impact.
- I62N (p.Ile62Asn), rs2146367925, ClinGen CA409103793, ClinVar RCV001763397, Ensembl rs2146367925, AlphaMissense 1.00, MetaLR 0.97, Uncertain significance, not provided
- I62V (p.Ile62Val), TOPMed rs2063496649, REVEL 0.73, MetaLR 0.83
- I62T (p.Ile62Thr), rs531178712, gnomAD 20-44402612-T-C, CADD 6.28
- G64R (p.Gly64Arg), rs769007443, ClinGen CA9870171, ClinVar RCV003993724, ClinVar RCV005030371, REVEL 0.95, MetaLR 0.94, Pathogenic, Monogenic diabetes
- G64V (p.Gly64Val), rs2515644510, NCI-TCGA Cosmic COSV5738, cosmic curated COSV57382, ClinGen CA409103809, Likely pathogenic, Monogenic diabetes
- D65A (p.Asp65Ala), Ensembl rs1600707598, Uncertain significance
- D65G (p.Asp65Gly), rs1600707598, ClinGen CA409103814, ClinVar RCV003231064, AlphaMissense 1.00, MetaLR 0.96, Uncertain significance, Maturity-onset diabetes of the young type 1
- D65V (p.Asp65Val), rs1600707598, ClinGen CA409103815, ClinVar RCV001773878, Ensembl rs1600707598, AlphaMissense 1.00, MetaLR 0.96, Uncertain significance, not provided
- R66Q (p.Arg66Gln), rs561302824, ClinGen CA9870173, ClinVar RCV001174366, ClinVar RCV002558767, CADD 1.69, SIFT 0.10, Conflicting interpretations, Monogenic diabetes; not provided; Maturity-onset diabetes of the young
- R66C (p.Arg66Cys), rs769620848, gnomAD 20-44402569-C-T, CADD 0.28
- R66S (p.Arg66Ser), rs769620848, gnomAD 20-44402569-C-A, CADD 0.21
- R66H (p.Arg66His), rs754042731, gnomAD 20-44402570-G-A, CADD 2.10
- R66G (p.Arg66Gly), rs542742235, gnomAD 20-44402584-A-G, CADD 1.94
- R66M (p.Arg66Met), gnomAD 20-44402585-G-T, CADD 2.42
Public HNF4A analysis runs
- HNF4A analysis run — HNF4A (794 variants) — completed 2026-08-20